Pramlintide for post-bariatric hypoglycaemia.

Amanda SheehanAllison GoldfineMuhammed BajwaDanielle WolfsChisayo KozukaJacqueline PiperKristen FowlerMary Elizabeth Patti

Published in: Diabetes, obesity & metabolism (2022)

In PBH, pramlintide does not modulate glycaemic or insulin responses, satiety, or dumping scores during an MMTT and does not impact glycaemic excursions or decrease low SG levels in the outpatient setting.

Keyphrases

type diabetes
glycemic control
weight loss
roux en y gastric bypass
insulin resistance
gastric bypass
adipose tissue
obese patients